World's Largest Physician Panel Formed As M3 USA Purchases EU-Based EMS
Research
M3 Global Research combines MDLinx and EMS to offer online access to 1.3 million healthcare professionals
Washington, DC, November 22, 2010 - M3 USA, parent company of MDLinx, a
leading medical market research firm, has signed an agreement to purchase
EU-based EMS Research, a company specializing in quantitative and
qualitative market research for clients in healthcare and other vertical
markets.
The acquisition creates the largest verified provider of physicians and
other healthcare professionals in the world. This new international
division will be designated M3 Global Research. With offices in the US, UK,
Germany, Japan, Korea and China, M3 Global Research will offer access to 1.3
million verified doctors and other healthcare professionals, differentiated
into more than 700 subspecialties.
M3 Global Research will provide the highest standard of direct access,
utilizing its proprietary physician panels, online survey tools, call
centers, fieldwork studios, and in-house project managers in offices around
the world.
"EMS Research has always prided itself on our superior market research
capabilities. By teaming with M3, we have greatly expanded the depth and
breadth of our abilities on a global perspective," said Neil Jarvis,
Director at EMS.
"Europe was the missing component in our market research global coverage
strategy. The EMS acquisition firmly secures our place as the healthcare
market research industry leader, and equips us with the largest verified
panel of healthcare professionals in the world," said Aki Tomaru, CEO of
M3 USA. "Our clients will now enjoy unparalleled global reach as they
gather insights from healthcare professionals and experience our
best-in-industry, single source service."
M3 Global Research and M3 USA
M3 Global Research is the market research division of Tokyo-based M3 Inc.
(JP:2413) operating globally with a proprietary healthcare professional
panel of 1.3 million respondents in more than 60 countries. The division
was created by uniting the worldwide panels of MDLinx in the USA, EMS
Research in Europe, and M3 companies across Asia. M3 Global Research offers
a broad range of capabilities including quantitative, qualitative, and
omnibus surveys utilizing call centers and in-country project managers. M3
has provided solutions for every top 20 pharmaceutical company in the world.
For more information, visit http://research.m3.com or email requests to research@usa.m3.com.
EMS Research
EMS Research, headquartered in London, England, was founded in 1999 and is
Europe's leading in-house medical fieldwork company. M3 Global Research
will maintain EMS's unparalleled research quality at competitive cost via
effective management and expansion of research assets across Europe,
including respondent databases, pan-European project teams, in-house
moderators, online survey tools, call centers, field teams and viewing
facilities.
Contact:
Greg Jones for M3 Global Research
908-310-3508
rgjones@mccpr.com
About Madison Park Group
Madison Park Group is an investment banking firm focused on advising technology and business services companies on pursuing M&A and private equity transactions. Madison Park Group's principals have extensive transaction and operating experience in the technology and business services sectors and have executed over $30 billion in financing and M&A transactions. For additional information, please visit www.madisonparkgrp.com |
